Multiple effects of probiotics on different types of diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials
Authors:
- Xia WangXWXia Wang
- Qi-Fang JuanQJQi-Fang Juan
- Yu-Wei HeYHYu-Wei He
- Li ZhuangLZLi Zhuang
- Yuan-Yuan FangYFYuan-Yuan Fang
- Yong-Hong WangYWYong-Hong Wang
- 24 May 2017
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 30 (6) , 611-622
Abstract
Background: A systematic review and meta-analysis was designed to evaluate the effect of probiotics on diabetes and its associated risk factors.Methods: We systematically searched the Cochrane Library, PubMed, EMBASE and Web of Science to June 2016. We also hand-searched the citation lists of included studies and previously identified systematic reviews to identify further relevant trials. Our primary outcome variables included glucose, glycated hemoglobin (HbA1c) and insulin. The pooled standardized mean difference was used to compare the effect between the probiotics and controlled groups, and the pooled standardized mean difference effect size with a 95% confidence interval (CI) was estimated using a random-effect model. Heterogeneity was assessed with Cochran’s Q and HigginsI2tests. Two reviewers assessed trial quality and extracted data independently. The analysis and bias for each included study was performed and assessed using Review Manager 5.2.Results: Eighteen randomized, placebo-controlled studies (n=1056 participants, 527 consuming probiotics, 529 not consuming probiotics) were included for analysis. Comparing the probiotics groups with the control groups, there were statistically significant pooled standardized mean differences on the reduction of glucose (−0.61, 95% CI −0.98, −0.24; p=0.001), insulin (−0.49, 95% CI −0.93, −0.04; p=0.03) and HbA1c(−0.39, 95% CI −0.60, −0.19%; p=0.0001). Subgroup analysis also indicated statistical significance on the reduction of low-density lipoprotein cholesterol (LDL-C) in non-type 2 diabetes (non-T2DM) mellitus patients with diabetes, for the pooled standardized mean difference was −0.29 (95% CI −0.54, −0.04; p=0.02).Conclusions: Probiotics may have beneficial effects on the reduction of glucose, insulin and HbA1cfor diabetes, especially for T2DM mellitus patients.Keywords
This publication has 37 references indexed in Scilit:
- Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot studyNutrition Journal, 2013
- Probiotics to Adolescents With ObesityJournal of Pediatric Gastroenterology and Nutrition, 2012
- Probiotic yogurt improves antioxidant status in type 2 diabetic patientsNutrition, 2012
- Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusLipids in Health and Disease, 2012
- Effects ofLactobacillus acidophilusNCFM on insulin sensitivity and the systemic inflammatory response in human subjectsBritish Journal of Nutrition, 2010
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- Functional and Probiotic Attributes of an Indigenous Isolate of Lactobacillus plantarumPLOS ONE, 2009
- Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cellsJournal of Hepatology, 2008
- Oral administration of dahi containing probioticLactobacillus acidophilusandLactobacillus caseidelayed the progression of streptozotocin-induced diabetes in ratsJournal of Dairy Research, 2008
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996